Smith & Nephew (LON:SN) Rating Reiterated by Berenberg Bank

Smith & Nephew (LON:SNGet Rating)‘s stock had its “buy” rating reiterated by research analysts at Berenberg Bank in a research report issued on Wednesday, November 9th, Marketbeat reports.

Other equities analysts have also issued research reports about the company. Royal Bank of Canada reissued an “outperform” rating and set a GBX 1,500 ($17.94) price objective on shares of Smith & Nephew in a research report on Monday, November 7th. Credit Suisse Group lowered their price target on shares of Smith & Nephew from GBX 1,540 ($18.42) to GBX 1,400 ($16.75) and set an “outperform” rating for the company in a research report on Thursday, August 4th. JPMorgan Chase & Co. cut their price objective on shares of Smith & Nephew from GBX 1,442 ($17.25) to GBX 1,243 ($14.87) and set a “neutral” rating on the stock in a report on Thursday, August 4th. Finally, Barclays lowered their target price on shares of Smith & Nephew from GBX 1,530 ($18.30) to GBX 1,500 ($17.94) and set an “overweight” rating for the company in a report on Friday, November 4th. One analyst has rated the stock with a hold rating and four have given a buy rating to the company. According to, Smith & Nephew presently has an average rating of “Moderate Buy” and an average price target of GBX 1,408.60 ($16.85).

Smith & Nephew Stock Down 0.6 %

Shares of LON:SN traded down GBX 7 ($0.08) during trading on Wednesday, hitting GBX 1,078.50 ($12.90). The stock had a trading volume of 1,583,306 shares, compared to its average volume of 343,671. The company has a quick ratio of 0.84, a current ratio of 1.78 and a debt-to-equity ratio of 53.62. Smith & Nephew has a 12 month low of GBX 959.20 ($11.48) and a 12 month high of GBX 1,357.50 ($16.24). The company has a market capitalization of £9.39 billion and a PE ratio of 2,294.68. The firm’s fifty day moving average is GBX 1,034.93 and its 200 day moving average is GBX 1,102.97.

Insider Buying and Selling at Smith & Nephew

In related news, insider Deepak Nath sold 1,170 shares of the business’s stock in a transaction that occurred on Monday, November 14th. The shares were sold at an average price of GBX 1,063 ($12.72), for a total value of £12,437.10 ($14,878.69).

About Smith & Nephew

(Get Rating)

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices worldwide. The company offers knee implant products for knee replacement procedures; hip implants for the reconstruction of hip joints; and trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures.

Recommended Stories

Analyst Recommendations for Smith & Nephew (LON:SN)

Receive News & Ratings for Smith & Nephew Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smith & Nephew and related companies with's FREE daily email newsletter.